Form 4: Bio-Rad Laboratories Executive Reports Stock Transaction
Insider Transaction (Form 4)
Sedat Evran, EVP, Global Supply Chain of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on October 20, 2026.
Summary
- Option exercise/conversion: acquired 1,044 Bio-Rad A Common Stock on October 20, 2026; holds 4,647 after (Direct).
- Tax/exercise-price withholding: disposed of 487 Bio-Rad A Common Stock at $354.50 ($172,642) on October 20, 2026; holds 4,160 after (Direct).
- Option exercise/conversion: disposed of 1,044 Restricted Stock Units on October 20, 2026; holds 1,044 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sedat Evran — Officer (EVP, Global Supply Chain)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-20 | Option exercise/conversion | Bio-Rad A Common Stock | 1,044 | — | — | 4,647.12 |
| 2026-10-20 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 487 | $355 | $172.6K | 4,160.12 |
| 2026-10-20 | Option exercise/conversion | Restricted Stock Units | 1,044 | — | — | 1,044 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-20 | Option exercise/conversion (1,044 shares) |
| 2026-10-20 | Tax/exercise-price withholding (487 shares) |
| 2026-10-20 | Option exercise/conversion (1,044 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Sedat Evran
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.